Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Antihypertensive Drugs, Prevention of Cognitive Decline and Dementia: A Systematic Review of Observational Studies, Randomized Controlled Trials and Meta-Analyses, with Discussion of Potential Mechanisms

(2015) Laure Rouch et al.   CNS DRUGS

The Spleen Tyrosine Kinase (Syk) Regulates Alzheimer Amyloid-β Production and Tau Hyperphosphorylation

(2014) Daniel Paris et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

(2014) Stephen Salloway et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series

(2012) Ihab Hajjar et al.   ARCHIVES OF NEUROLOGY

Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood–brain barrier

(2011) Corbin Bachmeier et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Unknown

(2011) Daniel Paris et al.   MOLECULAR MEDICINE

Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study

(2010) S. P. Kennelly et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

(2010) Juha O Rinne et al.   LANCET NEUROLOGY

Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons

(2009) L. B. Hoffman et al.   NEUROLOGY